Published in Hepatitis Weekly, May 6th, 1996
Susumu Takano, Kawasaki Chuo Hospital, Kawasaki, Japan, and colleagues evaluated the efficacy of the second-generation assay by performing a study based on data gathered from the Chiba University Hospital, Chiba, Japan ("Prospective Assessment of Donor Blood Screening for Antibody to Hepatitis C Virus by First- and Second-Generation Assays as a Means of Preventing Posttransfusion Hepatitis," Hepatology, April 1996;23(4):708-712). The authors believed this data to be representative of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.